Drug recall · July 8, 2026
Glucagon Emergency Kit for Low Blood Sugar recall
Why: CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Glucagon, 1 mL syringe, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-311-01
- Lots / codes
Kit Lots: WB00010, Exp. Date Jan 2027; WB00017, WB00019, Exp. Date Feb 2027; WB00070, Exp. Date Jun 2027; WB00077, WB00078, Exp. Date Jul 2027; WB00130, Exp. Date Nov 2027.
- Quantity
- 64,894 units
- Company
- Lupin Pharmaceuticals Inc., Naples, FL
- Distribution
- Nationwide within the U.S.
- Initiated
- June 23, 2026 · Voluntary: Firm initiated
- Classified
- July 23, 2026
- Reported
- July 8, 2026
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Glucagon
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.